论文信息 - Macrovesicular steatosis induced by interferon alfa therapy for chronic myelogenous leukaemia. - 字舞流文

Macrovesicular steatosis induced by interferon alfa therapy for chronic myelogenous leukaemia.

P. Bedossa | L. Castéra | C. Buffet | G. Tertian | E. Kalinsky

[1] P. Najarro,et al. Inhibition of Mitochondrial Function by Interferon* , 1996, The Journal of Biological Chemistry.

[2] N. Niederle,et al. Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia , 1992, The Lancet.

[3] Y. Berland,et al. Liver failure due to recombinant alpha interferon , 1991, The Lancet.

[4] F. Nosten,et al. Mefloquine for multidrug-resistant malaria , 1991, The Lancet.

[5] B. Stricker,et al. Fibrin ring granulomas and allopurinol. , 1989, Gastroenterology.

[6] M. Malaguarnera,et al. Effect of Interferon on Blood Lipids , 1996 .

[7] C. Trépo,et al. [Side effects of interferon-alpha]. , 1996, Gastroenterologie clinique et biologique.

[8] D. Pessayre,et al. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. , 1995, Pharmacology & therapeutics.

[9] V. Carreño,et al. Increase in triglicerides during α-interferon treatment of chronic viral hepatitis , 1992 .

[10] G. Danan. Consensus meetings on: Causality assessment of drug-induced liver injury , 1988 .